Sanofi Closes Sale of Controlling Stake in Opella to CD&R

MT Newswires Live
2025/05/01

Sanofi (SNY) said Wednesday it has closed the sale of a 50% controlling stake of its consumer healthcare business Opella to private equity firm CD&R for net cash proceeds of around 10 billion euros ($11.35 billion).

The healthcare company said it retains a 48.2% stake in Opella, with investment bank Bpifrance holding the remaining 1.8% stake and joining the board.

Sanofi said it is now a "pure-play biopharma" after the divestment.

The company's shares were up 1.8% in recent trading on Wednesday.

Price: 54.71, Change: +0.99, Percent Change: +1.84

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10